Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

An unheard benefit of phosphodiesterase inhibition

This article has been updated

Noise-induced hearing loss is caused primarily by damage to auditory hair cells; however, humans are unable to regenerate damaged hair cells, necessitating the development of new therapeutic strategies to protect auditory hair cells. A new study suggests that the use of phosphodiesterase 5 (PDE5) inhibitors may provide a protective therapeutic route for hearing loss (pages 252–259).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: PDE5 inhibition in the rodent inner ear provides protection against NIHL.

Katie Vicari

Change history

  • 08 February 2012

     In the version of this article initially published, vardenafil was incorrectly referred to as Cialis. The reference to Cialis has now been deleted in the text, and the title has been amended to 'An unheard benefit of phosphodiesterase inhibition'. The error has been corrected in the HTML and PDF versions of the article.

References

  1. Kopke, R.D. et al. Hear. Res. 226, 114–125 (2007).

    Article  PubMed  Google Scholar 

  2. Ohlemiller, K.K. Hear. Res. 245, 5–17 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Le Prell, C.G., Yamashita, D., Minami, S.B., Yamasoba, T. & Miller, J.M. Hear. Res. 226, 22–43 (2007).

    Article  PubMed  Google Scholar 

  4. Maison, S.F., Luebke, A.E., Liberman, M.C. & Zuo, J. J. Neurosci. 22, 10838–10846 (2002).

    Article  CAS  PubMed  Google Scholar 

  5. Oishi, N. & Schacht, J. Expert Opin. Emerg. Drugs 16, 235–245 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Jaumann, M. et al. Nat. Med. 18, 252–259 (2012).

    Article  CAS  PubMed  Google Scholar 

  7. Sabayan, B., Zamiri, N. & Farshchizarabi, S. Int. J. Neurosci. 120, 746–751 (2010).

    Article  CAS  PubMed  Google Scholar 

  8. Vlachopoulos, C., Terentes-Printzios, D., Ioakeimidis, N., Rokkas, K. & Stefanadis, C. Curr. Pharm. Des. 15, 3521–3539 (2009).

    Article  CAS  PubMed  Google Scholar 

  9. Francis, S.H., Busch, J.L., Corbin, J.D. & Sibley, D. Pharmacol. Rev. 62, 525–563 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Paquet-Durand, F. et al. J. Neurosci. 27, 10311–10319 (2007).

    Article  CAS  PubMed  Google Scholar 

  11. Giuliano, F., Jackson, G., Montorsi, F., Martin-Morales, A. & Raillard, P. Int. J. Clin. Pract. 64, 240–255 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Khan, A.S., Sheikh, Z., Khan, S., Dwivedi, R. & Benjamin, E. Laryngoscope 121, 1049–1054 (2011).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jian Zuo.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Layman, W., Zuo, J. An unheard benefit of phosphodiesterase inhibition. Nat Med 18, 206–207 (2012). https://doi.org/10.1038/nm.2647

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2647

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing